Carvedilol is a non-selective beta blocker with antioxidant properties approved for use in congestive heart failure. Carvedilol also possesses potent antioxidant and antiproliferative actions.

By contrast, a recent randomized, controlled trial shows less bleeding associated with the use of carvedilol compared with EBL. Portal hypertension is a life-threatening complication of cirrhosis ...

Carvedilol has the capacity to block both the β-1 and β-2 adrenergic receptors, as well as the α-1 receptors. There is evidence to indicate that full adrenergic blockade by carvedilol improves ...

Find all the commercial and brand names of generic drug called Carvedilol. This is an invaluable reference resource for healthcare professionals, patients, caregivers and anyone in need of ...

Maximum plasma concentrations of carvedilol occur 1-2 hours after oral administration. [9] Absolute bioavailability of carvedilol is approximately 23% due to extensive first-pass metabolism.